4Kscore
Selected indexed studies
- 4Kscore: Blurring the Lines Between Subjective and Objective Assessment. (Urol Pract, 2023) [PMID:37409949]
- 4Kscore diagnostic value in patients with high-grade prostate cancer using cutoff values of 7.5% to 10%: A meta-analysis. (Urol Oncol, 2021) [PMID:33685800]
- Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial. (Eur Urol, 2024) [PMID:38772787]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Screening for Prostate Cancer. (2020) pubmed
- 4Kscore: Blurring the Lines Between Subjective and Objective Assessment. (2023) pubmed
- 4Kscore diagnostic value in patients with high-grade prostate cancer using cutoff values of 7.5% to 10%: A meta-analysis. (2021) pubmed
- Performance of 4Kscore as a Reflex Test to Prostate-specific Antigen in the GÖTEBORG-2 Prostate Cancer Screening Trial. (2024) pubmed
- Optimum threshold of the 4Kscore for biopsy in men with negative or indeterminate multiparametric magnetic resonance imaging. (2023) pubmed
- Prostate Cancer Screening With PSA, Kallikrein Panel, and MRI: The ProScreen Randomized Trial. (2024) pubmed
- Implementation of 4Kscore as a Secondary Test Before Prostate Biopsy: Impact on US Population Trends for Prostate Cancer. (2023) pubmed
- Evaluation of the 4Kscore Test in Relation to Subsequent Risk of Aggressive Prostate Cancer in the European Prospective Investigation into Cancer and Nutrition. (2025) pubmed
- Transperineal vs Transrectal Prostate Biopsy-The PREVENT Randomized Clinical Trial. (2024) pubmed
- A 4Kscore Cut-off of 7.5% for Prostate Biopsy Decisions Provides High Sensitivity and Negative Predictive Value for Significant Prostate Cancer. (2021) pubmed